Status:

RECRUITING

EXOPULSE Mollii Suit, Motor Function & Stroke (EXOSTROKE 2)

Lead Sponsor:

Sheikh Shakhbout Medical City

Conditions:

Stroke

Spasticity, Muscle

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

The goal of this clinical trial is to demonstrate the improvement of motor functions related symptoms in patients with stroke and spasticity using Exopulse Mollii suit stimulation. The main questions...

Detailed Description

The study is a randomized crossover, sham-controlled, double-blind trial to demonstrate the improvement of motor functions and stroke related symptoms following a single session of "active" versus "sh...

Eligibility Criteria

Inclusion

  • Age between 18 and 75 years.
  • Having a clinical diagnosis of stroke since at least three months.
  • Being able to walk freely or with the need of support (modified Rankin score ≤ 4).
  • Able to understand verbal instructions.
  • Having spasticity with a score of at least 1+ on the MAS.
  • Having a BBS score ≤46 associated in the literature with a risk of fall.

Exclusion

  • Being included in another research protocol during the study period.
  • Inability to undergo medical monitor for the study purposes due to geographical or social reasons.
  • Having a cardiac stimulator, a ventriculoperitoneal shunt, an intrathecal baclofen pump or other contraindications to using EXOPULSE Mollii suit.
  • Being pregnant.
  • Having a change in their stroke pharmacological therapy in the last three months.
  • Suffering from other somatic or neuropsychiatric diagnoses (e.g., arrhythmias, uncontrolled epilepsy, diseases causing osteoarticular and muscular pain).
  • Having a body mass index above 35 Kg/m2.
  • In case of the introduction of a medical device other than EXOPULSE Mollii suit during the study period.
  • Patients under juridical protection.
  • Prisoners.

Key Trial Info

Start Date :

October 24 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 2 2024

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT06214975

Start Date

October 24 2023

End Date

December 2 2024

Last Update

January 22 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

SSMC

Abu Dhabi, United Arab Emirates

EXOPULSE Mollii Suit, Motor Function & Stroke (EXOSTROKE 2) | DecenTrialz